GSA Capital Partners’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-56,543
| Closed | -$336K | – | 1929 |
|
|
2017
Q4 | $336K | Buy |
+56,543
| New | +$336K | 0.02% | 1158 |
|
|
2017
Q3 | – | Sell |
-144,743
| Closed | -$983K | – | 1979 |
|
|
2017
Q2 | $983K | Buy |
+144,743
| New | +$983K | 0.06% | 556 |
|
|
2017
Q1 | – | Sell |
-18,890
| Closed | -$163K | – | 2113 |
|
|
2016
Q4 | $163K | Buy |
+18,890
| New | +$163K | 0.01% | 1633 |
|
|
2016
Q3 | – | Sell |
-13,100
| Closed | -$55K | – | 2066 |
|
|
2016
Q2 | $55K | Sell |
13,100
-375,200
| -97% | -$1.58M | ﹤0.01% | 1695 |
|
|
2016
Q1 | $1.69M | Sell |
388,300
-46,423
| -11% | -$202K | 0.11% | 254 |
|
|
2015
Q4 | $2.67M | Sell |
434,723
-43,101
| -9% | -$264K | 0.13% | 162 |
|
|
2015
Q3 | $2.73M | Buy |
477,824
+164,034
| +52% | +$938K | 0.13% | 147 |
|
|
2015
Q2 | $2.34M | Buy |
313,790
+128,199
| +69% | +$956K | 0.09% | 275 |
|
|
2015
Q1 | $1.11M | Buy |
185,591
+144,214
| +349% | +$863K | 0.04% | 779 |
|
|
2014
Q4 | $313K | Buy |
41,377
+20,497
| +98% | +$155K | 0.02% | 1237 |
|
|
2014
Q3 | $108K | Buy |
+20,880
| New | +$108K | 0.01% | 1616 |
|
|
2014
Q2 | – | Sell |
-10,080
| Closed | -$41K | – | 2024 |
|
|
2014
Q1 | $41K | Buy |
+10,080
| New | +$41K | ﹤0.01% | 1518 |
|